Association Between Insulin Resistance and Hepatic Fibrosis in Combined Chronic Hepatitis B and Non-alcoholic Fatty Liver Disease
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 500
- Locations
- 1
- Primary Endpoint
- Insulin resistance and fibrosis indices
Study Overview
Brief Summary
Hepatic steatosis and insulin resistance are associated with severity of fibrosis in non-alcoholic fatty liver disease (NAFLD) and chronic hepatitis C. However, clinical significance of steatosis and insulin resistance on fibrosis in chronic hepatitis B (CHB) is not well established. The aim was to investigate the relationship between insulin resistance, hepatic steatosis, and fibrosis in patients with CHB.
Detailed Description
acoustic radiation force impulse elastography
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 20 Years to 80 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Chronic hepatitis B patients
- •With evidences of hepatic steatosis on ultrasonography or pathology
Exclusion Criteria
- •significant alcohol consumption or other known liver diseases
Outcomes
Primary Outcomes
Insulin resistance and fibrosis indices
Time Frame: one year
Measurement for insulin resistance and fibrosis index for hepatic fibrosis assessment
Secondary Outcomes
No secondary outcomes reported
Investigators
Won Kim
M.D, PhD
Seoul National University Boramae Hospital
